{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:17:53Z","timestamp":1762273073399,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jcin.2023.03.051","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T14:39:58Z","timestamp":1683556798000},"page":"1103-1106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sex, Antithrombotics, and Outcomes\u00a0After TAVR"],"prefix":"10.1016","volume":"16","author":[{"given":"Giulia","family":"Masiero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Tarantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jcin.2023.03.051_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"ESC\/EACTS Scientific Document Group. 2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jcin.2023.03.051_bib2","first-page":"1164","article-title":"One-year outcomes and trends over two eras of transcatheter aortic valve implantation in real-world practice","volume":"11","author":"Costa","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"8","key":"10.1016\/j.jcin.2023.03.051_bib3","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/eurheartj\/ehx489","article-title":"Transcatheter aortic valve implantation in lower-risk patients: what is the perspective?","volume":"39","author":"Tarantini","year":"2018","journal-title":"Eur Heart J"},{"issue":"44","key":"10.1016\/j.jcin.2023.03.051_bib4","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1093\/eurheartj\/ehac385","article-title":"The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties","volume":"43","author":"Ten Berg","year":"2022","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jcin.2023.03.051_bib5","first-page":"E536","article-title":"Association between surgical risk and 30-day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis","volume":"97","author":"Matsuda","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.jcin.2023.03.051_bib6","first-page":"746","article-title":"Time course of the survival advantage of transcatheter over surgical aortic valve replacement: Interplay between sex and patient risk profile","volume":"94","author":"Ueshima","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"19","key":"10.1016\/j.jcin.2023.03.051_bib7","article-title":"Sex-specific considerations in degenerative aortic stenosis for female-tailored transfemoral aortic valve implantation management","volume":"11","author":"Masiero","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.jcin.2023.03.051_bib8","first-page":"876","article-title":"Four-year mortality in women and men after transfemoral transcatheter aortic valve implantation using the SAPIEN 3","volume":"97","author":"Tarantini","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2023.03.051_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/ehjcvp\/pvad003","article-title":"Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials","author":"Guedeney","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"2","key":"10.1016\/j.jcin.2023.03.051_bib10","article-title":"Sex differences among patients receiving edoxaban vs vitamin k antagonist for atrial fibrillation after transcatheter aortic valve replacement","volume":"2","author":"Mehran","year":"2023","journal-title":"JACC: Adv"},{"key":"10.1016\/j.jcin.2023.03.051_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.amjcard.2022.06.035","article-title":"Outcomes After transcatheter aortic valve implantation in men versus women","volume":"180","author":"W\u00f6hrle","year":"2022","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.jcin.2023.03.051_bib12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jcin.2023.02.039","article-title":"Sex differences in outcomes after transcatheter aortic valve replacement: a POPular TAVI subanalysis","volume":"16","author":"van Bergeijk","year":"2023","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"15","key":"10.1016\/j.jcin.2023.03.051_bib13","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.jcin.2023.03.051_bib14","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.jcin.2023.03.051_bib15","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.jacc.2019.09.015","article-title":"Sex differences in transfemoral transcatheter aortic valve replacement","volume":"74","author":"Vlastra","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2023.03.051_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.amjcard.2021.05.046","article-title":"Outcomes following aortic stenosis treatment (transcatheter vs surgical replacement) in women vs men (from a nationwide analysis)","volume":"154","author":"Deharo","year":"2021","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.jcin.2023.03.051_bib17","first-page":"114","article-title":"Gender differences after transcatheter aortic valve replacement (TAVR): insights from the Italian Clinical Service Project","volume":"8","author":"Denegri","year":"2021","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"issue":"17","key":"10.1016\/j.jcin.2023.03.051_bib18","first-page":"1285","article-title":"Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome","volume":"38","author":"Tarantini","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2023.03.051_bib19","doi-asserted-by":"crossref","unstructured":"Tarantini G, Cardaioli F. Antithrombotic therapy after TAVI: better alone than with a bad company. Catheter Cardiovasc Interv. Published online February 14, 2023. https:\/\/doi.org\/10.1002\/ccd.30589","DOI":"10.1002\/ccd.30589"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879823006866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879823006866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:18:03Z","timestamp":1761848283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879823006866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1936879823006866"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2023.03.051","relation":{},"ISSN":["1936-8798"],"issn-type":[{"type":"print","value":"1936-8798"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex, Antithrombotics, and Outcomes\u00a0After TAVR","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2023.03.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2023.02.039","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}